The prospect of tariffs on foreign-made pharmaceuticals had spurred fears of higher drug prices and shortages of critical medicines. But Mr. Trump’s announcement Thursday suggested that many of the most well-known and best-selling medicines could be exempt from the levies, potentially limiting their effect.